Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease.
Fellermann
K
K
Division of Gastroenterology, Department of Internal Medicine I, University of Lübeck, Lübeck, Germany.
Herrlinger
K R
KR
Witthoeft
T
T
Homann
N
N
Ludwig
D
D
Stange
E F
EF
D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D013256:Steroids; D011239:Prednisolone; D016559:Tacrolimus